Cargando…

Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?

Detalles Bibliográficos
Autores principales:	Lee, Chansu, Hong, Sung Noh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087921/ https://www.ncbi.nlm.nih.gov/pubmed/27784840 http://dx.doi.org/10.5009/gnl16438

Ejemplares similares

Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study
por: Shin, Cheol Min, et al.
Publicado: (2016)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

Gut microbiota and butyrate level changes associated with the long-term administration of proton pump inhibitors to old rats
por: Lee, Sun Min, et al.
Publicado: (2019)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study
por: Takagi, Tomohisa, et al.
Publicado: (2018)

Proton pump inhibitor use associated with changes in gut microbiota composition
por: Reveles, Kelly R, et al.
Publicado: (2018)

Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
por: Hojo, Mariko, et al.
Publicado: (2018)

Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota
por: Zhang, Jiayi, et al.
Publicado: (2023)

Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats
por: Yang, Yu-Chen S. H., et al.
Publicado: (2020)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
por: Graham, David Y., et al.
Publicado: (2017)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

When does proton pump inhibitor treatment become long term? A scoping review
por: Haastrup, Peter Fentz, et al.
Publicado: (2021)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015)

Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Proton-pump inhibitor use does not affect semen quality in subfertile men
por: Keihani, Sorena, et al.
Publicado: (2018)

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
por: Maideen, Naina Mohamed Pakkir
Publicado: (2023)

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
por: Horvath, Angela, et al.
Publicado: (2019)

Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
por: Holmberg, Dag, et al.
Publicado: (2022)

Can proton pump inhibitors cause intestinal inflammation in children?
por: Kang, Ben
Publicado: (2019)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment
por: Chen, Hao, et al.
Publicado: (2023)

Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
por: Tsuda, Ayumi, et al.
Publicado: (2015)

The risks of long-term use of proton pump inhibitors: a critical review
por: Jaynes, Megan, et al.
Publicado: (2018)

Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2019)

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper
por: Raoul, Jean-Luc, et al.
Publicado: (2022)

Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy
por: DiGiovanni, Ernest L., et al.
Publicado: (2016)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
por: Shin, Cheol Min, et al.
Publicado: (2016)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Rebuilding trust in proton pump inhibitor therapy
por: Turshudzhyan, Alla, et al.
Publicado: (2022)

Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor
por: Imai, Ryosuke, et al.
Publicado: (2017)

Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults
por: Zirk‐Sadowski, Jan, et al.
Publicado: (2018)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Do Proton Pump Inhibitor–refractory Laryngeal Symptoms Represent a True Acid-related Disease?
por: Hong, Kwon-Eui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2tsbh60ik1e7rkg9db40nekm1a